• RQ3025 and Broad-Spectrum SARS-CoV-2 Vaccination

  2026-08-24

  Lu et al. characterize RQ3025, a mutation-aware bivalent mRNA vaccine designed to broaden neutralization across SARS-CoV-2 variants. Across mouse, hamster, and rat models, the vaccine induced broad antibody responses, supported protection in rats, promoted a Th1-biased cellular response, and showed no evident organ pathology after high-dose administration.

• Lipo3K Transfection Reagent for Kidney Organoids

  2026-08-24

  Lipo3K Transfection Reagent enables practical DNA, siRNA, and co-transfection workflows for kidney models, including challenging organoid-derived cells. This guide translates a DDIT4-centered microplastic nephrotoxicity study into reproducible assay design, optimization, and troubleshooting strategies.

• Batimastat (BB-94) in MMP Assays and Cancer Research

  2026-08-23

  Batimastat (BB-94) is a broad-spectrum hydroxamate MMP inhibitor for dissecting protease-dependent tumor invasion, angiogenesis, and extracellular signaling. This workflow also shows how carefully controlled MMP inhibition can extend neuromuscular-junction studies without confusing exploratory synapse biology with validated cancer-model evidence.

• Sabutoclax: Separating Growth Arrest from Cell Death

  2026-08-22

  Sabutoclax is a pan-Bcl-2 inhibitor whose apparent potency can reflect both proliferation arrest and apoptosis. This guide applies a phenotype-first framework to improve assay interpretation, endpoint selection, and translational decision-making.

• T-5224: AP-1 Selectivity and Ferroptosis

  2026-08-22

  T-5224 is a selective C-Fos/AP-1 inhibitor for dissecting inflammatory, osteoclastogenic, and cancer-cell pathways. This article connects established arthritis pharmacology with new evidence that AP-1 blockade can promote ferroptosis through PI3K/AKT signaling, while translating those findings into practical assay decisions.

• RNASEH1-AS1 in Hepatocellular Carcinoma

  2026-08-21

  A 2024 study integrates TCGA analysis, prognostic modeling, and cellular validation to characterize RNASEH1-AS1 as an oncogenic lncRNA associated with poor hepatocellular carcinoma outcomes. Its findings connect RNASEH1-AS1 expression with tumor grade, immune infiltration, co-expressed RNA-processing genes, and DKC1-dependent RNA stability, while also defining important limits for clinical translation.

• RNASEH1-AS1 in Hepatocellular Carcinoma: Study Insights

  2026-08-20

  The reference study integrates TCGA-based transcriptomic analysis, prognostic modeling, and laboratory validation to identify RNASEH1-AS1 as an oncogenic lncRNA associated with hepatocellular carcinoma progression. Its findings connect RNASEH1-AS1 expression with tumor grade, survival, immune infiltration, and DKC1-dependent RNA stability, while also defining a four-gene risk model for further evaluation.

• PVT1–HIF-1α Feedback in Pancreatic Cancer

  2026-08-20

  The 2021 reference study identifies a reciprocal regulatory loop in which the lncRNA PVT1 enhances HIF-1α transcription and protein regulation in pancreatic cancer. Its integrated expression, promoter, RNA–protein interaction, and functional assays provide a mechanistic framework for understanding how hypoxia-associated signaling may sustain tumor progression.

• Q-VD(OMe)-OPh in Multimodal Cell Death Studies

  2026-08-19

  Q-VD(OMe)-OPh is a broad-spectrum caspase inhibitor for dissecting apoptosis alongside ferroptosis and autophagy. This guide translates findings from cetuximab-resistant colorectal cancer research into practical assay and interpretation strategies.

• HO-1 and ROS Modulation in HBV Replication

  2026-08-19

  The reference study shows that isochlorogenic acid A suppresses HBV at multiple stages, linking HO-1 upregulation and intracellular ROS modulation to reduced viral gene expression, cccDNA, and defective particle morphogenesis. Its multi-readout design provides a useful framework for distinguishing effects on replication, capsid assembly, and envelopment while identifying limitations for translation beyond cell-based models.

• Epigenetic Silencing in Integrated Genetic Circuits

  2026-08-18

  The reference study shows that heterogeneous expression from CRISPR-Cas9-integrated multi-transcript circuits is driven primarily by local chromatin accessibility and epigenetic silencing rather than detectable sequence alteration. Its combination of fluorescent phenotyping, methylation and histone deacetylation perturbation, and ATAC-seq provides a practical framework for evaluating circuit stability in mammalian cells.

• Cy5-UTP for Fluorescent RNA Probe Synthesis

  2026-08-18

  Cy5-UTP enables direct, far-red visualization of RNA generated by T7 in vitro transcription, supporting FISH, expression-array workflows, and RNA delivery QC. This practical guide covers labeling design, assay controls, optimization, and the limitations of transferring fluorescent-tracer strategies into mRNA nanoparticle studies.

• AZD6482: PI3Kβ Precision for Translational Research

  2026-08-17

  AZD6482 is a selective, ATP-competitive PI3Kβ inhibitor that connects isoform-resolved kinase biology with platelet, metabolic, and hypothesis-driven disease-modeling workflows. This article examines its mechanistic value, experimental validation strategy, translational positioning, and cautious application to differentiation-dependent RNA-foci research in myotonic dystrophy type 1.

• 2-NBDG Glucose Uptake Assay Kit in HCC

  2026-08-17

  Learn how the 2-NBDG Glucose Uptake Assay Kit can separate glucose transport phenotypes from lipid-driven ferroptosis resistance in hepatocellular carcinoma. This evidence-based guide connects single-cell fluorescence with rigorous metabolic interpretation.

• Biotin-16-UTP: From RNA Labeling to Translation

  2026-08-16

  A mechanistic and strategic guide to using Biotin-16-UTP for in vitro RNA labeling, RNA-protein interaction studies, and translational investigation of lncRNA biology, with RNASEH1-AS1 in hepatocellular carcinoma as a model for moving from computational association to experimentally testable mechanism.

8030 records 1/536 page Next 12345 下5页 Last page